Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Nov. 30, 2018 |
Nov. 30, 2017 |
Nov. 30, 2018 |
Nov. 30, 2017 |
|
| Condensed Consolidated Statements Of Operations And Comprehensive Loss | ||||
| Revenue | ||||
| Operating Expenses - | ||||
| Research and development | 792,111 | 3,894,454 | 2,924,483 | 5,341,763 |
| General and administrative | 1,971,847 | 2,720,078 | 6,721,796 | 4,691,294 |
| Depreciation and amortization | 155,053 | 98,755 | 366,710 | 281,016 |
| Interest expense | 14,883 | 41,117 | ||
| Foreign exchange (gain) loss | (20,133) | (9,634) | (72,404) | 88,634 |
| Total operating expenses | 2,913,761 | 6,703,653 | 9,981,702 | 10,402,707 |
| Net Loss | (2,913,761) | (6,703,653) | (9,981,702) | (10,402,707) |
| Other comprehensive loss - | ||||
| Foreign currency translation adjustment | (91,249) | 155,354 | (202,838) | (2,068) |
| Comprehensive Loss | $ (3,005,010) | $ (6,548,299) | $ (10,184,540) | $ (10,404,775) |
| Loss per share | ||||
| Basic and Diluted | $ (0.09) | $ (0.20) | $ (0.30) | $ (0.32) |
| Weighted average common shares outstanding | ||||
| Basic and Diluted | 33,805,706 | 32,793,181 | 33,792,293 | 32,183,343 |